Pingie: HTTP:: FDA Probes Weight Loss Drug Alli for Liver Damage

HTTP:: FDA Probes Weight Loss Drug Alli for Liver Damage
--------
After approving Alli, the weight-loss drug, for sale over the counter in the US in 2007, the Food and Drug Administration is now investigating claims that it may lead to liver damage, following 32 reports from people who have taken it. For the time being, the FDA says people on orlistat (brand name Alli) should continue taking it without fear, but they should immediately refer to a doctor if they notice any symptoms associated with liver problems, BizJournals informs. Alli is one of the most promising weight-loss drugs now available on the market without a prescription. Despite several warnings from health specialists as to its long-term pros and cons, Glaxo, the manufacturer, insists it entails no health risks. As for the most recent allegations that it can cause liver damage, there is no connection between taking Alli and any symptoms of the kind, the company states. “Alli is a ‘non-systemically’ acting medicine â€" it is minimally absorbed in the blood and work!
s locally in the gastro-intestinal tract. There is therefore no obvious biological mechanism to explain how liver damage can occur with Alli.” Deborah G. Bolding, GlaxoSmithKline spokesperson, says in light of the recent complaints with the FDA. However, the Association is forced into taking action by the “...
--------
http://news.softpedia.com/news/FDA-Probes-Weigh-Loss-Drug-Alli-for-Liver-Damage-120123.shtml This e-mail was sent by Experiment23 Inc., located in New York, NY
10163. To not receive further e-mails, please visit
http://help.pingie.com